# Repeated Neural Stem Cell Based Virotherapy for Newly Diagnosed High Grade Glioma

> **NCT06169280** · PHASE1 · RECRUITING · sponsor: **Northwestern University** · enrollment: 20 (estimated)

## Conditions studied

- Glioma, Malignant
- New Diagnosis Tumor

## Interventions

- **BIOLOGICAL:** NSC-CRAd-S-pk7

## Key facts

- **NCT ID:** NCT06169280
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-27
- **Primary completion:** 2029-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06169280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06169280, "Repeated Neural Stem Cell Based Virotherapy for Newly Diagnosed High Grade Glioma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06169280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*